BRIEF-Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing

Eli Lilly and Company

Eli Lilly and Company

LLY

0.00

July 20 (Reuters) - Scribe Therapeutics Inc SCTX.O:

  • SCRIBE THERAPEUTICS - IPO PRICE EXPECTED BETWEEN $13 AND $15 PER SHARE - SEC FILING

  • SCRIBE THERAPEUTICS - LAUNCHES IPO OF 7,150,000 COMMON SHARES - SEC FILING

  • SCRIBE THERAPEUTICS - AVENTIS AND GENZYME TO PURCHASE $7.50 MILLION IN SHARES VIA CONCURRENT PRIVATE PLACEMENT - SEC FILING

  • SCRIBE THERAPEUTICS INC - ELI LILLY HAS INDICATED INTEREST IN PURCHASING CO'S SHARES OF COMMON STOCK AT IPO PRICE

Source text: [ID:n0001193125-26-308330]

Further company coverage: SCTX.O


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.